Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor for Poor Stem Cell Mobilization
NCT01037517Phase 2Completed
- Sponsor
- CancerCare Manitoba
- Start
- Jan 2010
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in multiple myeloma (MM), lymphoma, sponsored by CancerCare Manitoba. Started Jan 2010; status: completed.
02
Drugs
plerixafor
03
Conditions
multiple myeloma (MM)lymphoma
Beyond the preview
Go deeper on NCT01037517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01037517.